Dramatic Response to Alectinib in a Critically Ill Elderly Patient with Lung Adenocarcinoma Due to Trousseau Syndrome and Disseminated Intravascular Coagulation-Reference-Cited by-同舟云学术

Dramatic Response to Alectinib in a Critically Ill Elderly Patient with Lung Adenocarcinoma Due to Trousseau Syndrome and Disseminated Intravascular Coagulation

Published:2022-01-15 Issue:2 Volume:61 Page:229-232
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hamada Noboru¹,Tada Yusaku¹,Hisamatsu Kazuya¹,Yamamoto Yukichika¹,Yamano Takafumi¹

Affiliation:

1. Department of Respiratory Medicine, Okayama City Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/2/61_7048-21/_pdf

Reference13 articles.

1. 1. Akamatsu H, Ninomiya K, Kenmotsu H, et al. The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV. Int J Clin Oncol 24: 731-770, 2019.

2. 2. Trousseau A. Phlegmasia alba dolens. In: Clinique Medicale de l'Hotel-Dieu de Paris. 2nd ed. JB Bailliere, Paris, 1865: 654-712.

3. 3. Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 107: 117-121, 2003.

4. 4. Iwama E, Goto Y, Murakami H, et al. Alectinib for patients with ALK rearrangement-positive non-small cell lung cancer and a poor performance status (Lung Oncology Group in Kyushu 1401). J Thorac Oncol 12: 161-166, 2017.

5. 5. Yoshida T, Hida T, Yatabe Y. Rapid and dramatic response to alectinib in an anaplastic lymphoma kinase rearranged non-small-cell lung cancer patient who is critically ill. Anticancer Drugs 27: 573-575, 2016.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy for lung cancer with paraneoplastic disseminated intravascular coagulation: A case report and pooled analysis;Clinical Lung Cancer;2022-12